Amyloid Beta (A4) Precursor Protein: A Potential Biomarker for Recurrent Nasopharyngeal Carcinoma

References

• Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108. doi:10.3322/caac.2126225651787
   PubMed Web of Science ®Google Scholar
• Chen ZT, Liang ZG, Zhu XD. A review: proteomics in nasopharyngeal carcinoma. Int J Mol Sci. 2015;16(7):15497–15530. doi:10.3390/ijms16071549726184160
   PubMed Web of Science ®Google Scholar
• Nicholson BD, Shinkins B, Pathiraja I, et al. Blood CEA levels for detecting recurrent colorectal cancer. Cochrane Database Syst Rev. 2015;(12):CD011134. doi:10.1002/14651858.CD011134.pub226661580
   PubMed Web of Science ®Google Scholar
• Li GP, Wang H, Lai YK, et al. Proteomic profiling between CNE-2 and its strongly metastatic subclone S-18 and functional characterization of HSP27 in metastasis of nasopharyngeal carcinoma. Proteomics. 2011;11(14):2911–2920. doi:10.1002/pmic.20100048321717573
   PubMed Web of Science ®Google Scholar
• Xiao Z, Li G, Chen Y, et al. Quantitative proteomic analysis of formalin-fixed and paraffin-embedded nasopharyngeal carcinoma using iTRAQ labeling, two-dimensional liquid chromatography, and tandem mass spectrometry. J Histochem Cytochem. 2010;58(6):517–527. doi:10.1369/jhc.2010.95552620124091
   PubMed Web of Science ®Google Scholar
• Seriramalu R, Pang WW, Jayapalan JJ, et al. Application of champedak mannose-binding lectin in the glycoproteomic profiling of serum samples unmasks reduced expression of alpha-2 macroglobulin and complement factor B in patients with nasopharyngeal carcinoma. Electrophoresis. 2010;31(14):2388–2395. doi:10.1002/elps.20100016420575108
   PubMed Web of Science ®Google Scholar
• Tang CE, Tan T, Li C, et al. Identification of Galectin-1 as a novel biomarker in nasopharyngeal carcinoma by proteomic analysis. Oncol Rep. 2010;24:2. doi:10.3892/or_00000884
   Web of Science ®Google Scholar
• Cho WC, Yip TT, Yip C, et al. Identification of serum amyloid a protein as a potentially useful biomarker to monitor relapse of nasopharyngeal cancer by serum proteomic profiling. Clin Cancer Res. 2004;10:43–52. doi:10.1158/1078-0432.CCR-0413-314734450
   PubMed Web of Science ®Google Scholar
• Diamandis EP. Identification of serum amyloid a protein as a potentially useful biomarker for nasopharyngeal carcinoma. Clin Cancer Res. 2004;10(15):5293–5294. doi:10.1158/1078-0432.CCR-04-037715297433
   PubMed Web of Science ®Google Scholar
• Yang X, Dai W, Kwong DL, et al. Epigenetic markers for noninvasive early detection of nasopharyngeal carcinoma by methylation-sensitive high resolution melting. Int J Cancer. 2015;136(4):E127–135. doi:10.1002/ijc.2919225196065
   PubMed Web of Science ®Google Scholar
• Meng HL, Zhu XD, Li L, et al. Identification of novel serum biomarkers for rNPC using TMT-based quantitative proteomic analysis. Chin J Oncol Prev Treat. 2017;9(3):167–171. doi:10.3969/j.issn.1674-5671.2017.03.01
   Google Scholar
• Sandberg A, Branca RM, Lehtio J, Forshed J. Quantitative accuracy in mass spectrometry based proteomics of complex samples: the impact of labeling and precursor interference. J Proteomics. 2014;96:133–144. doi:10.1016/j.jprot.2013.10.03524211767
   PubMed Web of Science ®Google Scholar
• White NM, Masui O, Desouza LV, et al. Quantitative proteomic analysis reveals potential diagnostic markers and pathways involved in pathogenesis of renal cell carcinoma. Oncotarget. 2014;5(2):506–518. doi:10.18632/oncotarget.152924504108
   PubMed Web of Science ®Google Scholar
• Stoker SD, Van Diessen JN, De Boer JP, et al. Current treatment options for local residual nasopharyngeal carcinoma. Curr Treat Options Oncol. 2013;14(4):475–491. doi:10.1007/s11864-013-0261-524243165
   PubMed Web of Science ®Google Scholar
• Li JG, Chen XZ, Lin SJ, HU CS. Expert consensus on the treatment of recurrent nasopharyngeal carcinoma. Chin J Radiat Oncol. 2018;27(1):16–22. doi:10.3760/cma.j.issn.1004-4221.2018.01.002
   Google Scholar
• Janvilisri T. Omics-based identification of biomarkers for nasopharyngeal carcinoma. Dis Markers. 2015;2015:762128. doi:10.1155/2015/76212825999660
   PubMed Web of Science ®Google Scholar
• Luftig M. Heavy LIFting: tumor promotion and radioresistance in NPC. J Clin Invest. 2013;123(12):4999–5001. doi:10.1172/JCI7341624270417
   PubMed Web of Science ®Google Scholar
• Woods NK, Padmanabhan J. Inhibition of amyloid precursor protein processing enhances gemcitabine-mediated cytotoxicity in pancreatic cancer cells. J Biol Chem. 2013;288(42):30114–30124. doi:10.1074/jbc.M113.45925524022491
   PubMed Web of Science ®Google Scholar
• Zheng KL, He TL, JI WP, et al. Alternative splicing of NUMB, APP and VEGFA as the features of pancreatic ductal carcinoma. Int J Clin Exp Pathol. 2015;8(6):6181–6191. PMID: 26261495.26261495
   PubMed Web of Science ®Google Scholar
• Takayama K, Tsutsumi S, Suzuki T, et al. Amyloid precursor protein is a primary androgen target gene that promotes prostate cancer growth. Cancer Res. 2009;69(1):137–142. doi:10.1158/0008-5472.CAN-08-363319117996
   PubMed Web of Science ®Google Scholar
• Miyazaki T, Ikeda K, Horie-Inoue K, Inoue S. Amyloid precursor protein regulates migration and metalloproteinase gene expression in prostate cancer cells. Biochem Biophys Res Commun. 2014;452(3):828–833. doi:10.1016/j.bbrc.2014.09.01025218471
   PubMed Web of Science ®Google Scholar
• Meng JY, Kataoka H, Itoh H, Koono M. Amyloid beta protein precursor is involved in the growth of human colon carcinoma cell in vitro and in vivo. Int J Cancer. 2015;92(1):31–39. doi:10.1002/1097-0215(200102)9999:9999<::AID-IJC1155>3.0.CO;2-H
   Google Scholar
• Tang CE, Guan YJ, Yi B, Li XH, Liang K. Identification of the amyloid β-protein precursor and cystatin C as novel epidermal growth factor receptor regulated secretory proteins in nasopharyngeal carcinoma by proteomics. J Proteome Res. 2010;9(12):6101–6111. doi:10.1021/pr100663p20882990
   PubMed Web of Science ®Google Scholar
• Forbes SA, Bindal N, Bamford S, Cole C, Kok CY. COSMIC: mining complete cancer genomes in the catalogue of somatic mutations in cancer. Nucleic Acids Res. 2011;39(Database issue):D945–D950. doi:10.1093/nar/gkq92920952405
   PubMed Web of Science ®Google Scholar
• Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012;2(5):401–404. doi:10.1158/2159-8290.CD-12-009522588877
   PubMed Web of Science ®Google Scholar
• Hansel DE, Rahman A, Wehner S, Herzog V, Yeo CJ. Increased expression and processing of the alzheimer amyloid precursor protein in pancreatic cancer may influence cellular proliferation. Cancer Res. 2003;63(21):7032–7037. PMID: 14612490.14612490
   PubMed Web of Science ®Google Scholar
• Pietrzik CU, Hoffmann J, Stöber K, Chen CY, Bauer C. From differentiation to proliferation: the secretory amyloid precursor protein as a local mediator of growth in thyroid epithelial cells. Proc Natl Acad Sci USA. 1998;95:1770–1775. doi:10.1073/pnas.95.4.17709465092
   PubMed Web of Science ®Google Scholar